Format

Send to

Choose Destination
Ann Hematol. 2003 Oct;82(10):654-9. Epub 2003 Jul 4.

Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.

Author information

1
Medizinische Klinik und Poliklinik V, Universit├Ąt Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany. hartmut_goldschmidt@med.uni-heidelberg.de
PMID:
12845480
DOI:
10.1007/s00277-003-0685-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center